Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-0232-2026

Tandem Diabetes Care, Inc. recalls t:slim X2 insulin pump with Interoperable Technology

Tandem Diabetes Care, Inc.San Diego, CA, United StatesReported Oct 29, 2025 · 8 months ago
Legal News Analyst ·

Reason for recall

A software defect in versions 7.9.0.1 and 7.10.1 of the pump software for Tandem t:slim X2 and version 7.9.0.1 of the Tandem Mobi pump with Control-IQ+ technology that are paired with a G7 sensor may result in an unexpected automatic insulin correction bolus (autobolus ) which could result in hypoglycemia.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

t:slim X2 insulin pump with Interoperable Technology, Control-IQ+ technology5 codes
  • 1014070
  • 1014071
  • 1014072
  • 1014073
  • and User Guide when using Dexcom G7 sensor
Tandem Mobi insulin pump with Interoperable Technology, Control-IQ+ technology4 codes
  • 1014801
  • 1014811
  • 1014813
  • and User Guide when using Dexcom G7 sensor

Lot / code information

UDI
00389152407012, 00389152407111, 00389152407210, 00389152407319 with software versions 7.9.0.1 and 7.10.1, User Guide versions not including and prior to: AW-1014562 Revision D; Tandem Mobi
UDI
00389152480114, 00389152481111, 00389152481319 with software version 7.9.0.1, User Guide versions not including and prior to: AW-1014938 Revision C

What the firm is doing

On 8/5/2025, Field Safety Notices were sent to customers informing them of the following: Actions to avoid the issue: - Wait until your G7 sensor session ends before inserting a new G7 sensor. - However, if you do insert a new G7 sensor before your last sensor session ends, wait to pair until at least 20 minutes after the last session ends. Firm is working on a software update to resolve this issue. If you have questions or need help, please call firm's Customer Support 1-877-801-6901 or email Techsupport@tandemdiabetes.com. Our team is available 24/7/365. On 9/16/2025, correction notices were emailed to customers who were informed the firm updated user guides to align with instructions in the correction notice. Also, the firm will notify impacted users via an updated Field Correction Notice when the software update is available. The notice will provide instructions on how to remotely update their software.

DistributionShow details

US nationwide distribution including Puerto Rico.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls